Sukanya D, Upasana L, Deepak T A, Abhinethra M S, Choudary Sailaja
Department of Oral Medicine and Radiology, V.S. Dental College and Hospital, Bengaluru, Karnataka, India.
J Pharm Bioallied Sci. 2022 Jul;14(Suppl 1):S475-S478. doi: 10.4103/jpbs.jpbs_673_21. Epub 2022 Jul 13.
Oral submucous fibrosis (OSMF) is chronic, scarring disease of the oral cavity. Cytokines and growth factors produced by inflammatory cells play a major role in its pathogenesis. Low-level laser therapy (LLLT) application, which has an anti-inflammatory, was used to determine the improvement in mouth opening.
The aim of the study is to evaluate the effectiveness of laser photobiomodulation (PBM) in OSMF treatment.
Thirty patients who were diagnosed with OSMF after obtaining consent form and ethical clearance were included. LLLT was applied for 4 cycles for 15 s each in the left and right buccal mucosa. Therapy was done on day 0, 3, 7, and 15 and measurements were done immediately after each LLLT application. Patients were recalled after 1, 3, and 6 months from the commencement of the therapy for follow-up measurements.
The mean increase in mouth opening following application of LLLT from day 0 to day 15 was 9.91 ± 3.34, and day 1-6 months was 14.29 ± 6.82, which was statistically significant.
The study shows significant improvements in the mouth opening of the OSMF patient during treatment and postoperatively. Thus, our study confirms LLLT can be used as one of the modality in OSMF management.
口腔黏膜下纤维化(OSMF)是一种口腔慢性瘢痕性疾病。炎症细胞产生的细胞因子和生长因子在其发病机制中起主要作用。应用具有抗炎作用的低强度激光疗法(LLLT)来确定张口度的改善情况。
本研究的目的是评估激光光生物调节(PBM)在OSMF治疗中的有效性。
纳入30例在获得同意书并通过伦理审查后被诊断为OSMF的患者。在左右颊黏膜各应用LLLT 4个周期,每个周期15秒。在第0、3、7和15天进行治疗,并在每次LLLT应用后立即进行测量。从治疗开始1、3和6个月后召回患者进行随访测量。
从第0天到第15天应用LLLT后张口度的平均增加为9.91±3.34,在第1天至6个月时为14.29±6.82,具有统计学意义。
该研究表明,在治疗期间和术后,OSMF患者的张口度有显著改善。因此,我们的研究证实LLLT可作为OSMF治疗的一种方式。